Live Breaking News & Updates on Biodelivery Sciences International

Stay updated with breaking news from Biodelivery sciences international. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Life sci consulting firm Santander makes its debut

Life sci consulting firm Santander makes its debut
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

North-carolina , United-states , Robert-yanez , Michelle-yanez , Amira-pharmaceuticals , Valeant-pharmaceuticals , Johnson , Biodelivery-sciences-international , Bausch-health , Santander-pharma-consulting , Pharma-marketing , Collegium-pharmaceutical

Chronic Lower Back Pain Market is expected to rise at a CAGR of 3.85% during the study period (2019–2032), estimates DelveInsight |

Chronic Lower Back Pain Market is expected to rise at a CAGR of 3.85% during the study period (2019–2032), estimates DelveInsight |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

United-states , United-kingdom , Japan , Vertanical-gmb , Eli-lilly , Braeburn-inc , Chronic-lower-back-pain-companies , Discgenics-inc , Pfizer , Healthcare-market-research , Frontier-biotechnologies-inc , Persica-pharmaceuticals

COLL Stock Price | Collegium Pharmaceutical Inc. Stock Quote (U.S.: Nasdaq)

COLL | Complete Collegium Pharmaceutical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ....

Etby-tomi-kilgore , Biodelivery-sciences-international-inc , Biodelivery-sciences-international , Coll , Oll-analyst-estimates , Oll-earnings-estimates , Oll-share-estimates , Oll-analyst-recommendations , Poll-ratings , Ollegium-pharmaceutical-inc-analyst-estimates , Ollegium-pharmaceutical-inc-earnings-estimates , Ollegium-pharmaceutical-inc-analyst-recommendations

Processa Pharmaceuticals (NASDAQ: PCSA): Revolutionizing Cancer Treatment through Next-Generation Chemotherapies

Processa Pharmaceuticals’ (NASDAQ: PCSA) shares skyrocketed by over 260% from their October lows of $0.18 per share. Shares peaked at $0.65 on November 14th and more recently has consolidated around $0.43. The reason for this surge was not immediately clear given the lack of material events. However upon digging deeper, we’ve uncovered a very interesting […] ....

David-young , Young , Spectrum-pharmaceuticals-inc , Management-team , Questcor-pharmaceuticals , Biodelivery-sciences-international-inc , Scilex-holding-co , Research-development , Sorrento-therapeutics-inc , Nasdaq , University-of-maryland-school-pharmacy , Scilex-pharmaceuticals-inc

Cary biotech startup lands licensing deal for potential chronic itchy skin treatment

Avior Bio, a small Cary startup developing a treatment for pruritus, or chronic itchy skin, has secured an agreement to license its clinical-stage therapy to a New Jersey pharmaceutical company. ....

Bridgewater , North-carolina , United-states , New-jersey , Hillstream-biopharma , Randy-milby , Niraj-vasisht , Biodelivery-sciences-international , Tharimmune-inc , Carolina-biotechnology-center , Avior-bio , North-carolina-biotechnology